392 related articles for article (PubMed ID: 17194181)
41. Gene-expression Profiling in Non-small Cell Lung Cancer with Invasion of Mediastinal Lymph Nodes for Prognosis Evaluation.
Grigoroiu M; Tagett R; Draghici S; Dima S; Nastase A; Florea R; Sorop A; Ilie V; Bacalbasa N; Tica V; Laszlo V; Mansuet-Lupo A; Damotte D; Klepetko W; Popescu I; Regnard JF
Cancer Genomics Proteomics; 2015; 12(5):231-42. PubMed ID: 26417026
[TBL] [Abstract][Full Text] [Related]
42. Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy.
Ulloa-Montoya F; Louahed J; Dizier B; Gruselle O; Spiessens B; Lehmann FF; Suciu S; Kruit WH; Eggermont AM; Vansteenkiste J; Brichard VG
J Clin Oncol; 2013 Jul; 31(19):2388-95. PubMed ID: 23715562
[TBL] [Abstract][Full Text] [Related]
43. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
[TBL] [Abstract][Full Text] [Related]
44. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
Zhong S; Fields CR; Su N; Pan YX; Robertson KD
Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
[TBL] [Abstract][Full Text] [Related]
45. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer.
Ji P; Diederichs S; Wang W; Böing S; Metzger R; Schneider PM; Tidow N; Brandt B; Buerger H; Bulk E; Thomas M; Berdel WE; Serve H; Müller-Tidow C
Oncogene; 2003 Sep; 22(39):8031-41. PubMed ID: 12970751
[TBL] [Abstract][Full Text] [Related]
46. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S
Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897
[TBL] [Abstract][Full Text] [Related]
47. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.
Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S
Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260
[TBL] [Abstract][Full Text] [Related]
48. A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients.
Tang H; Xiao G; Behrens C; Schiller J; Allen J; Chow CW; Suraokar M; Corvalan A; Mao J; White MA; Wistuba II; Minna JD; Xie Y
Clin Cancer Res; 2013 Mar; 19(6):1577-86. PubMed ID: 23357979
[TBL] [Abstract][Full Text] [Related]
49. A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC).
Azad AK; Qiu X; Boyd K; Kuang Q; Emami M; Perera N; Palepu P; Patel D; Chen Z; Cheng D; Feld R; Leighl NB; Shepherd FA; Tsao MS; Xu W; Liu G; Cuffe S
Lung Cancer; 2014 Jun; 84(3):289-94. PubMed ID: 24679952
[TBL] [Abstract][Full Text] [Related]
50. hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer.
Wang L; Soria JC; Kemp BL; Liu DD; Mao L; Khuri FR
Clin Cancer Res; 2002 Sep; 8(9):2883-9. PubMed ID: 12231532
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non-Small-Cell Lung Cancer.
Woodard GA; Wang SX; Kratz JR; Zoon-Besselink CT; Chiang CY; Gubens MA; Jahan TM; Blakely CM; Jones KD; Mann MJ; Jablons DM
Clin Lung Cancer; 2018 Jan; 19(1):58-64. PubMed ID: 28645632
[TBL] [Abstract][Full Text] [Related]
52. Gene copy number aberrations are associated with survival in histologic subgroups of non-small cell lung cancer.
Micke P; Edlund K; Holmberg L; Kultima HG; Mansouri L; Ekman S; Bergqvist M; Scheibenflug L; Lamberg K; Myrdal G; Berglund A; Andersson A; Lambe M; Nyberg F; Thomas A; Isaksson A; Botling J
J Thorac Oncol; 2011 Nov; 6(11):1833-40. PubMed ID: 22011649
[TBL] [Abstract][Full Text] [Related]
53. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
[TBL] [Abstract][Full Text] [Related]
54. RANTES expression is a predictor of survival in stage I lung adenocarcinoma.
Moran CJ; Arenberg DA; Huang CC; Giordano TJ; Thomas DG; Misek DE; Chen G; Iannettoni MD; Orringer MB; Hanash S; Beer DG
Clin Cancer Res; 2002 Dec; 8(12):3803-12. PubMed ID: 12473593
[TBL] [Abstract][Full Text] [Related]
55. A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies.
Kratz JR; He J; Van Den Eeden SK; Zhu ZH; Gao W; Pham PT; Mulvihill MS; Ziaei F; Zhang H; Su B; Zhi X; Quesenberry CP; Habel LA; Deng Q; Wang Z; Zhou J; Li H; Huang MC; Yeh CC; Segal MR; Ray MR; Jones KD; Raz DJ; Xu Z; Jahan TM; Berryman D; He B; Mann MJ; Jablons DM
Lancet; 2012 Mar; 379(9818):823-32. PubMed ID: 22285053
[TBL] [Abstract][Full Text] [Related]
56. Analysis of gene expression profiles of non-small cell lung cancer at different stages reveals significantly altered biological functions and candidate genes.
Wang J; Song J; Gao Z; Huo X; Zhang Y; Wang W; Qi J; Zheng S
Oncol Rep; 2017 Mar; 37(3):1736-1746. PubMed ID: 28098899
[TBL] [Abstract][Full Text] [Related]
57. Systematic analysis of mRNA expression profiles in NSCLC cell lines to screen metastasis-related genes.
Liu Y; Liu L; Yu T; Lin HC; Chu D; Deng W; Yan MX; Li J; Yao M
Mol Med Rep; 2016 Dec; 14(6):5093-5103. PubMed ID: 27840927
[TBL] [Abstract][Full Text] [Related]
58. Predicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of development.
Liu H; Kho AT; Kohane IS; Sun Y
PLoS Med; 2006 Jul; 3(7):e232. PubMed ID: 16800721
[TBL] [Abstract][Full Text] [Related]
59. A Predictive 7-Gene Assay and Prognostic Protein Biomarkers for Non-small Cell Lung Cancer.
Guo NL; Dowlati A; Raese RA; Dong C; Chen G; Beer DG; Shaffer J; Singh S; Bokhary U; Liu L; Howington J; Hensing T; Qian Y
EBioMedicine; 2018 Jun; 32():102-110. PubMed ID: 29861409
[TBL] [Abstract][Full Text] [Related]
60. Nomogram integrating gene expression signatures with clinicopathological features to predict survival in operable NSCLC: a pooled analysis of 2164 patients.
Wu J; Zhou L; Huang L; Gu J; Li S; Liu B; Feng J; Zhou Y
J Exp Clin Cancer Res; 2017 Jan; 36(1):4. PubMed ID: 28057025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
